drugset / Trial / NCT00023621

Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

NCT00023621 ↗

RandomizedDouble-blindPrevention

Summary

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. The use of celecoxib may be an effective way to prevent the development of basal cell carcinoma. PURPOSE: Randomized phase II trial to determine the effectiveness of celecoxib in preventing basal cell carcinoma in patients who have basal cell nevus syndrome.

Timeline

Start
2001-02
Primary completion
—
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified — Oral

Indications